Eps8, a substrate of receptor tyrosine kinases, is an SH3 domain containing protein that plays an important role in mitogenic signaling. To determine the cellular function of eps8, we used the SH3 domain of eps8 to screen a human ®broblast M426 expression library and identi®ed, a full-length cDNA clone of 3.2 kb. We designated this clone e3B1 for eps8 SH3 domain binding protein 1. Northern analysis revealed that expression of e3B1 mRNA was ubiquitious in human tissues. . We further determined that the p65 e3B1 was the most abundant in serum-starved NIH/ EGFR cells. Time course studies initiated by the addition of epidermal growth factor (EGF) revealed that the p72 e3B1 started to accumulate at 4 h, peaked at 8 h and remained high until 24 h. Finally, we demonstrate that NIH/EGFR ®broblasts overexpressing e3B1 grow more slowly relative to matched controls.
Eps8, a substrate of receptor tyrosine kinases, is an SH3 domain containing protein that plays an important role in mitogenic signaling. To determine the cellular function of eps8, we used the SH3 domain of eps8 to screen a human ®broblast M426 expression library and identi®ed, a full-length cDNA clone of 3.2 kb. We designated this clone e3B1 for eps8 SH3 domain binding protein 1. Northern analysis revealed that expression of e3B1 mRNA was ubiquitious in human tissues. The e3B1 gene encodes a SH3 domain containing protein. We show that anti-e3B1 antibodies detect three cytosolic protein species of 65, 68 and 72 kDa in cell lysate isolated from asynchronously growing NIH3T3 cells. E3B1 binds to the SH3 domain of eps8 and Abl in vitro. We also demonstrated that e3B1 associates with eps8 in vivo. Phosphatase digestion and phosphoamino acid analysis revealed that p65 e3B1 is a phosphoserine containing protein and p72 e3B1 and p68 e3B1 are hyperserine-phosphorylated form of p65 e3B1 . We further determined that the p65 e3B1 was the most abundant in serum-starved NIH/ EGFR cells. Time course studies initiated by the addition of epidermal growth factor (EGF) revealed that the p72 e3B1 started to accumulate at 4 h, peaked at 8 h and
Introduction
Many cellular activities such as proliferation, differentiation and metabolism are controlled by extracellular signaling molecules such as polypeptide growth factors. The eects of many growth factors are known to be mediated by transmembrane receptor tyrosine kinases (Schlessinger and Ullrich, 1992 ; Van der Geer et al., 1994) . Following ligand binding and dimerization, the intrinsic protein tyrosine kinase activity of the growth factor receptor is stimulated, leading to receptor autophosphorylation and subsequent phosphorylation of speci®c cellular substrates. Using an expression cloning approach, we previously identi®ed eps8 as a substrate for the epidermal growth factor receptor (EGFR) tyrosine kinase as well as several other receptor tyrosine kinases (Fazioli et al., 1993a; Wong et al., 1994) . Eps8 binds to the EGFR despite of the lack of a SH2 domain. Thus, unlike other SH2 domain containing substrates such as Grb2 and phospholipase Cg (PLCg), tyrosine phosphorylation of the receptor is not required for its interaction with eps8 (Castagnino et al., 1995) . The eps8 binding site on the EGFR was mapped to the juxtamembrane region of the receptor (Castagnino et al., 1995) . Overexpression of eps8 in EGFR expressing ®broblasts and hematopoietic cells enhances the mitogenic response to EGF in these cells (Fazioli et al., 1993a) . In NIH3T3 ®broblasts which express low numbers of EGFR, overexpression of eps8 results in cellular transformation upon addition of EGF (Matoskova et al., 1995) . In contrast, EGF treatment induces transformation of neither NIH3T3 ®broblasts nor NIH3T3 ®broblasts overexpressing PLCg (Matoskova et al., 1995) . Steady state tyrosine phosphorylation of eps8, but not several other tyrosine kinase substrates, has been detected in several tumor cell lines, indicating that eps8 might be part of a pathway preferentially selected for tumor growth (Matoskova et al., 1995) . Together, these observations suggest that eps8 plays a critical role in mitogenic signaling.
Sequence analysis of eps8 showed that the molecule possesses an SH3 domain, an element found in a variety of proteins, including adaptors such as Grb2 and the p85 subunit of PI3K, the Src, Crk, and Abl oncoproteins, and structural proteins such as spectrin (Pawson, 1995; Cohen et al., 1995) . SH3 domains are involved in protein-protein interactions, and the SH3 binding sites within several proteins have been mapped to proline-rich sequences (Pawson, 1995; Cohen et al., 1995) . SH3 domains have been shown to play diverse roles including regulation of enzyme activity, intracellular targeting, recruitment of substrates, and assembly of multisubunit enzymes (Cohen et al., 1995) .
In order to further de®ne the role of eps8 in mitogenic signaling, we sought to identify proteins that interact with the SH3 domain of eps8. In this study, we report the isolation and characterization of a 65 kDa eps8-SH3-domain-binding protein, e3B1.
Results

Isolation and characterization of e3B1 cDNA
To identify proteins physically associated with the eps8 SH3 domain, we screened a human embryonic ®broblast M426 expression library with the glutathione S-transferase (GST) eps8 SH3 domain fusion protein. Upon screening 5.5610 6 plaques, we identi®ed 39 positive clones. Further analysis by cross-hybridization allowed us to group these positive clones into six groups of distinct cDNAs (data not shown). We designated these cDNA clones as e3B for eps8 SH3 domain binding.
Among these 39 positive clones, 24 clones belonged to the e3B1 group. The longest e3B1 cDNA clone, clone 78, contained a cDNA insert of 3.2 kb. Figure  1 shows the complete nucleotide sequence of the longest e3B1 clone. The e3B1 cDNA contains an open reading frame (ORF) for 480 amino acid residues with the initiation codon at nucleotide positions 67 ± 69 and the termination codon at nucleotide positions 1507 ± 1509. The ORF of e3B1 encodes a protein with a predicted molecular weight of 52.4 kDa and a pI of 6.9. Within the 3' noncoding region, a polyadenylation sequence AATAAA, at nucleotide positions 3169 ± 3173, is located 15 nucleotides before the poly A tail.
Analysis of the e3B1 cDNA and expression of e3B1 mRNA Analysis of the e3B1 ORF revealed a protein comprised of 11% proline residues. The majority of prolines (42%) are located between residues 337 and 391 ( Figure 2a ). The central region of the protein is rich in serine and threonine residues (residues 168 ± 334). Seventy percent and 51% of all the serine and threonine residues, respectively, are located in this central region, a likely target for regulation by serine/ threonine kinases. There are three putative phosphorylation sites (S/T-P-X-K/R) for cyclin-dependent kinases (Nigg, 1993) and seven putative sites (S/T-P) for MAP kinases (Clark-Lewis et al., 1991) . The carboxyterminal region of the putative protein contains an SH3 domain (residues 425 ± 477) (Figure 2a) , which is closely related to the SH3 domains of cortactin (54% identity), a substrate of the Src tyrosine kinase, and is distantly related to the SH3 domain of eps8 (26% identity). Three PEST motifs (residues 205 ± 219, 250 ± 287 and 366 ± 418), sequences shown to be involved in protein destabilization (Rechsteiner, 1990) , are also found (Figure 2a) .
A DNA sequence database search revealed that e3B1 shares sequence similarity with the Xenopus laevis gene xlan4 (Reddy et al., 1991) , the mouse gene Abi-1 (Shi et al., 1995) and the human gene Abi-2 (Dai and Pendergast, 1995) . The Xenopus laevis xlan4 gene encodes a material transcript localized to the animal pole region of oocytes and its expression is developmentally regulated. Abi-1 and Abi-2 gene products were identi®ed as proteins physically associating with the Abl oncoprotein. At the amino acid level, sequence similarities between the e3B1 gene product and xlan4, Abi-1, and Abi-2 are 68%, 85% and 62%, respectively (Figure 2b ). Based on the sequence similarity between these proteins, it is likely that Abi-1 is the murine homologue of e3B1 while xlan4 is the Xenopus homologue of Abi-2. E3B1 and Abi-2 are likely to be (7), and (.) was inserted for maximal alignment between the e3B1 amino acid sequence and the sequence of xlan4, Abi-1 or Abi-2
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To examine the expression of mRNA encoded by e3B1, we performed Northern blot analysis of poly(A) + RNA extracted from dierent human tissues. Using an e3B1 probe which contained only the coding nucleotide sequence, a major band of 3.4 kb and a minor band of 2.6 kb were detected in all the human tissues analysed ( Figure 3 ). These results suggest that the longest e3B1 cDNA in clone 78 is likely to be full-length. Furthermore, the level of e3B1 mRNA expression was very similar in all these human tissues as judged by the expression of the glyceraldehyde 3'-phosphate dehydrogenase (GAPDH) mRNA in these tissues.
The e3B1 gene product
To characterize the e3B1 gene product, we subcloned the ORF into the pGEX-KG vector and expressed it in bacteria as a GST fusion protein. We used the GSTe3B1 fusion protein as an immunogen to raise polyclonal antibodies. These antibodies speci®cally recognized three proteins of 65, 68 and 72 kDa in NIH3T3 lysates prepared from asynchronously growing cells (Figure 4a ). To further con®rm that these three proteins are products of the e3B1 gene, we subcloned the ORF into an eukaryotic expression vector, pCEV27 (Miki and Aaronson, 1993) , transfected the construct into NIH3T3 cells, and analysed lysates from e3B1 transfectants with our speci®c antibodies. As shown in Figure 4b , the anti-e3B1 antibodies detected the same three proteins of 65, 68 and 72 kDa in NIH-e3B1 cells as in NIH3T3 cells. Furthermore, the levels of all three proteins were higher (approximately threefold) in NIH-e3B1 cells compared to NIH3T3 cells.
To investigate the nature of the three dierent molecular weight products detected by the anti-e3B1 antibodies, we immunoprecipitated e3B1 proteins from cell lysates isolated from asynchronously growing NIH3T3 ®broblasts and then treated these proteins with calf intestinal alkaline phosphatase. As shown in Figure 5a , treatment of immunoprecipitated e3B1 proteins with phosphatase converted the 72 kDa and the 68 kDa forms into the 65 kDa form. In addition, the 65 kDa form of e3B1 in the phosphatase treated sample migrated slightly faster than its counterpart in the untreated sample. The conversion process by phosphatase treatment was blocked if phosphatase inhibitors were added to the digestion reaction mixture (Figure 5a ).
To further examine the three forms of e3B1, e3B1 proteins were immunoprecipitated with the anti-e3B1 antibodies from [ Immunoblot analysis of total cell lysates isolated from NIH3T3 cells overexpressing e3B1. Total cellular proteins were prepared from stable mass colonies of asynchronously growing NIH3T3 cells transfected with either the pCEV vector (NIH3T3) or the pCEV-e3B1 vector (NIH-e3B1). Two milligrams of total cellular proteins were immunoprecipitated with the anti-e3B1 antibodies. The immunoprecipitants were separated by 10% SDS ± PAGE and analysed by immunoblotting with the anti-e3B1 antibodies as described in Materials and methods. Molecular size markers are shown on kilodaltons the results from phosphatase digestion and phosphoamino acid analysis experiments suggest that the e3B1 gene is expressed as a 65 kDa phosphoserine containing protein in the cell which migrates on the gel as 68 and 72 kDa forms upon additional serine phosphorylation. We designate the gene product of e3B1 as p65 e3B1 and its hyperphosphorylated forms as p68 e3B1 and p72 e3B1 .
Binding of e3B1 to SH3 domains in vitro
To investigate the interaction of e3B1 with SH3 domains derived from SH3 domain containing molecules, puri®ed GST fusion proteins containing the SH3 domain of Src, Fyn, GAP, PLC-g, Abl, Grb2, Crk and Nck were immobilized on glutathione-agarose, mixed with lysates isolated from asynchronously growing NIH3T3 ®broblasts, and proteins bound to the GST fusion proteins were analysed by Western blotting with the anti-e3B1 antibodies. As shown in Figure 6 , equivalent molar amounts of GST fusion proteins were loaded as determined by Western analysis using the anti-GST antibodies (lower panel). Both the SH3 domain of eps8 and Abl were able to capture e3B1 from cell lysate. Neither the GST protein nor the GST-SH3 domain of Src, Fyn, GAP, Grb2, PLC-g, Crk and Nck SH3 domain 1 interact with e3B1 in vitro.
Together, these experiments show that e3B1 preferentially binds to the SH3 domains of eps8 and Abl.
Binding of e3B1 to eps8
We further investigated whether e3B1 binds eps8 in vitro. GST-e3B1 was immobilized on glutathioneagarose, mixed with lysates isolated from asynchronously growing NIH3T3 ®broblasts, and proteins bound to the GST fusion proteins were analysed by immunoblotting with the anti-eps8 antibodies. Figure 7a shows that immobilized GST-e3B1 was able to capture p97 eps8 from cell lysates. Unlike GST-e3B1 proteins, immobilized GST proteins did not bind eps8 in vitro.
To determine whether e3B1 associates with eps8 in vivo, we immunoprecipitated e3B1 from NIH/EGFR cells with the anti-e3B1 antibodies and analysed the immunoprecipitates with the anti-eps8 antibodies by immunoblotting. As shown in Figure 7b , p97 eps8 was detected in anti-e3B1 immunoprecipitates but not in control immunoprecipitates. In addition, we also examined anti-eps8 immunoprecipitates from lysate of NIH/EGFR cells transfected with pCEV-e3B1 by immunoblotting with the anti-e3B1 antibodies. Only the p65 e3B1 but not p68 e3B1 or p72 e3B1 was detected in the anti-eps8 immunoprecipitates (Figure 7b ). Unlike antieps8 immunoprecipitates, no e3B1 was detected in control immunoprecipitates. A low but detectable amount of p65 e3B1 was also observed in anti-eps8 immunoprecipitates from NIH/EGFR cell lysate (data not shown). Therefore, these experiments demonstrate that e3B1 associates with eps8 in vivo.
Phosphorylation of e3B1 during cell growth and subcellular distribution of e3B1
To examine e3B1 phosphorylation as a function of the cell cycle, we treated serum-starved NIH/EGFR cells with EGF, lysed the cells at various time points and performed immunoblot analysis using the anti-e3B1 antibodies. Figure 8 shows that both p72 e3B1 and p65 e3B1 were identi®ed in asynchronously growing NIH/EGFR cells. In contrast, p65 e3B1 was the most abundant in serum-starved cells, and did not change signi®cantly until 4 h after EGF treatment, when p72 e3B1 began to appear. Accumulation of the p72 e3B1 peaked at 8 h and remained at a similar level until 24 h following addition of EGF. At 24 h, most of the p72 e3B1 was converted back p65 e3B1 . Similar patterns of e3B1 phosphorylation were detected in cells treated with serum instead of EGF (data not shown). These experiments show that phosphorylation of p65 e3B1 is regulated during the cell cycle.
To investigate the subcellular distribution of e3B1, proteins isolated from serum-starved or asynchronously growing NIH/EGFR cells were fractionated into cytosolic, nuclear and membrane components and analysed by immunoblotting using anti-e3B1 antibodies as a probe. As shown in Figure 9 , all three forms of the e3B1 protein were localized to the cytosolic fraction. Furthermore, the distribution was similar in serumstarved and asynchronously growing NIH/EGFR cells. These experiments demonstrate that e3B1 is mainly a cytosolic protein.
Overexpression of e3B1 inhibits cell growth
In an eort to determine a function for e3B1 in vivo, we transfected NIH/EGFR cells with the pCEV-e3B1 plasmid, obtaining stable mass colonies overexpressing e3B1, and analysed their growth parameters. Initial attempts to establish stable mass colonies overexpressing e3B1 were not successful. Subsequently, we determined that continuous addition of geneticin to the culture medium was required to maintain e3B1 overexpression and that the level of e3B1 expression in e3B1 transfectants decreased to that seen in untransfected cells if geneticin was removed from culture medium for more than 2 weeks (data not shown). As shown in Figure 10 , the level of e3B1 in pCEV-e3B1 transfected mass colonies (NIH/EGFR-e3B1) was about threefold higher than in matched mass colonies transfected with vector alone (NIH/EGFR-pCEV). During a 9 day time course, NIH/EGFR-e3B1 cells showed a slower rate of growth compared to the NIH/ EGFR-pCEV cells. Furthermore, the cell density at con¯uence was observed to be lower in e3B1 transfectants than in matched control cells ( Figure  10 ). Similar results were obtained from three independent transfected mass colonies of NIH/EGFR cells and One hundred micrograms of total cellular proteins were separated by 10% SDS ± PAGE and analysed by immunoblotting with the anti-e3B1 antibodies as described in Materials and methods from two independent transfected colonies of NIH3T3 cells. These experiments demonstrate that overexpression of e3B1 in NIH/EGFR cells alters cell growth in a negative manner.
Discussion
Emerging evidence indicates that eps8, a substrate for several receptor tyrosine kinases, is likely involved in the mitogenic signaling pathways (Fazioli et al., 1993a; Matoskova et al., 1995) . To study the role of eps8 in mitogenic signaling, we have used the SH3 domain of eps8 to screen a M426 expression library for proteins that interact with eps8. We have identi®ed a 3.2 kb cDNA clone, designated e3B1. The predicted e3B1 gene product contains two unique regions in its carboxy-terminus, a proline-rich region and a SH3 domain. The proline-rich region of e3B1 is probably the binding site for the SH3 domain of eps8 because this proline-rich region was preserved in the shortest cDNA clone (contains residues 336 ± 480) we isolated. In addition to the SH3 domain of eps8, we also demonstrated that the SH3 domain of Abl is able to interact with e3B1 in vitro. Our results are in agreement with previous report showing that Abi-1, the putative mouse homologue of e3B1, is a Abl binding protein (Shi et al., 1995) . The binding site of the SH3 domain of Abl is likely located at the proline-rich region of e3B1. The consensus PXXP motif, previously identi®ed as an Abl-SH3-domain-binding sequence (Ren et al., 1993) , could be identi®ed in several locations within the proline-rich region of e3B1. In addition to our observations, Abi-1 was identi®ed as an SH3 domain containing protein that binds to the proline-rich region in the carboxy-terminal part of Abl (Shi et al., 1995) . Therefore, e3B1 and Abl might interact with each other by a dual SH3 domain/proline-rich sequence association mechanism.
In asynchronously growing NIH3T3 cells or NIH/ EGFR ®broblasts, anti-e3B1 antibodies detected three forms of e3B1, p65 e3B1 , p68 e3B1 and p72
e3B1
. p65 e3B1 is a phosphoserine-containing protein and p68 e3B1 and p72 e3B1 are hyperserine-phosphorylated forms of p65 e3B1 . Coimmunoprecipitation experiments revealed that only the p65 e3B1 but not p68 e3B1 and p72 e3B1 is able to interact with eps8 in vivo. These results suggest that phosphorylation of p65 e3B1 might be a mechanism for the dissociation of e3B1 from eps8. We are currently investigating this possibility.
Time course studies of the phosphorylation of e3B1 showed that the major species of e3B1 in serum-starved NIH/EGFR cells is p65 e3B1 . After addition of EGF to the cells, the p72 e3B1 began to accumulate at 4 h, peaked at 8 h and remained relatively constant until 24 h after the EGF treatment. At that point, most of the e3B1 protein returns to p65 e3B1 . We have determined by FACS analysis that the onset of S phase of the cell cycle in these cells occurs 10 ± 12 h after addition of EGF or serum, and the cells re-enter another cell cycle after 24 h (Piccoli and Wong, unpublished observations). Therefore, it is possible that serine/threonine kinases active in the G 1 phase might be involved in the phosphorylation of e3B1. Examination of the e3B1 sequence revealed that there are three potential phosphorylation sites (T/S-P-X-K/R) for cyclin-dependent kinases (CDKs) (Nigg, 1993), T 196 , S 216 and S 225 , in the central serine and threonine-rich region. Among these three potential CDK phosphorylation sites, two of them, SPAR and SPGR at residues 216 ± 219 and 225 ± 228, respectively, contain serine residues. The conversion of p65 e3B1 to p68 e3B1 and p72 e3B1 might be the results of phosphorylation of these two serine residues by CDKs. We are in the process of determining whether e3B1 is a substrate for G 1 CDKs.
Overexpression of e3B1 in NIH/EGFR ®broblasts reduced cell growth, suggesting that e3B1 might play a role in regulating cell proliferation. In agreement with this observation, Shi et al. have shown that e3B1 suppresses v-Abl transforming activity in NIH3T3 cells (Shi et al., 1995) . The identi®cation of e3B1 as a downstream target for the receptor tyrosine kinase substrate, eps8, and the determination of the role of e3B1 in regulating cell growth contribute an important step in understanding the role of eps8 in growth factor receptor signaling. At present, we do not know how eps8 aects the cellular function of e3B1. We have previously demonstrated that eps8 plays a positive role in mitogenic signaling (Fazioli et al., 1993a; Matoskova et al., 1995) . Therefore, we postulate that eps8 is probably a negative regulator of the growth inhibitory function of e3B1. We are currently examining this possibility with eps8 mutants which lack e3B1 binding sites. These studies will likely provide insights linking growth factor receptor signaling to cell cycle regulation.
Materials and methods
Isolation and characterization of the e3B1 cDNA
A GST-fusion protein containing the SH3 domain of eps8 (amino acid residues 532 to 591) was used to screen a pCEV-LAC expression library constructed from human embryonic ®broblasts M426 mRNAs, a kind gift from Dr Toru Miki (Miki and Aaronson, 1993) . Duplicate ®lters generated from recombinant plaques after IPTG induction were blocked in 2% (w/v) bovine serum albumin (BSA) in TTBS (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05% Tween 20) for 2 h at room temperature (RT), and incubated in a solution containing 3 mM reduced glutathione (Sigma), 0.5% (w/v) BSA and TTBS for 1 h. After washing with TTBS, ®lters were incubated with GSTeps8SH3 fusion protein or GST protein in 3 mM reduced glutathione (Sigma), 0.5% (w/v) BSA and TTBS for 1 h. To reduce non-speci®c background, the GST or the GSTeps8SH3 fusion proteins probe was pre-mixed with TTBS containing 3 mM reduced glutathione (Sigma), 0.5% (w/v) BSA for at least 1 h before applying to the ®lters. Following incubation with the protein probe, the ®lters were extensively washed with TTBS and bound GST or GST-eps8SH3 fusion proteins were detected with anitypuri®ed anti-GST antibodies as described (Sastry et al., 1995) . Clones detected by GST-eps8SH3 fusion protein but not by GST protein were further puri®ed to homogeneity. The cDNA inserts in the positive phages were sequenced by automated DNA sequencing. DNA sequence analysis was carried out using the GCG program (University of Wisconsin) and sequence database search was performed by the BLAST program (Altschul et al., 1990) .
Northern analysis
DNA probes used for Northern blot analysis were labeled using a nick translation kit (Amersham). The e3B1 probe consisted of the entire e3B1 cDNA. The human glyceraldeIsolation and characterization of e3B1 Z Biesova et al hyde 3'-phosphate dehydrogenase (GAPDH) probe was synthesized from a cDNA clone purchased from ATCC. Northern blot analysis was performed on commercial human multiple tissue Northern blots (Clontech) . Hybridizations were performed as recommended by the manufacturer.
Generation of antisera against e3B1
The coding region of e3B1 clone 78 (nucleotides 67 ± 1509) was ampli®ed by PCR and cloned in-frame into the XbaI and SalI sites of pGEX-KG vector. GST-e3B1 fusion proteins were puri®ed as described (Guan and Dixon, 1991) , and used to immunize rabbits to generate e3B1 speci®c antibodies. Anti-e3B1 antibodies were anity puri®ed by ®rst absorbing the antiserum through a GST column to remove antibodies speci®c for GST and then by applying to a GST-e3B1 anity column. Both GST and GST-e3B1 columns were generated using the aminolink reagents (Pierce) as described by the manufacturer.
